Señales en vivo de MOB.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 05:07):

Stats
Volumen de hoy	66 428.00
Volumen promedio	595 336
Capitalización de mercado	958.52M
EPS	SEK0 ( 2024-02-12 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-14
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-25.77
ATR14	SEK0.120 (0.35%)

Volumen Correlación

Largo: -0.02 (neutral)

Corto: 0.75 (moderate)

Signal:(59.459) Neutral

Moberg Pharma AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Moberg Pharma AB (publ) Correlación - Moneda/Commodity

0.14
( neutral )

0.10
( neutral )

0.00
( neutral )

0.01
( neutral )

0.50
( neutral )

-0.44
( neutral )

Moberg Pharma AB (publ) Finanzas

Annual	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-2.10M (0.00 %)
EPS:	SEK-1.330

FY	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-2.10M (0.00 %)
EPS:	SEK-1.330

FY	2022
Ingresos:	SEK207 000
Beneficio Bruto:	SEK-2.38M (-1 147.34 %)
EPS:	SEK-1.380

FY	2021
Ingresos:	SEK0.00
Beneficio Bruto:	SEK0.00 (0.00 %)
EPS:	SEK0.238

Financial Reports:

No articles found.

Moberg Pharma AB (publ)

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.